文献速递肾小球疾病遗传性与小管间质肾病

激素抵抗型肾病综合征患者的全外显子组测序

Whole Exome Sequencing of Patients with Steroid-Resistant Nephrotic Syndrome.
PubMed 文献 · Clin J Am Soc Nephrol · 2017-11-10

在25%的家庭中检出致病突变,其中38%为近亲家庭,13%为非近亲家庭,48%为先天性肾病综合征患儿。全外显子组测序是诊断单基因病因的敏感方法,分子遗传诊断可能影响治疗和肾移植管理。

要点

  • 全外显子组测序在25%的激素抵抗型肾病综合征家庭中检出已知基因的致病突变。
  • 近亲家庭、非近亲家庭和先天性肾病综合征患儿的突变检出率分别为38%、13%和48%。
  • 分子遗传诊断可能对激素抵抗型肾病综合征的治疗和肾移植管理产生重要影响。

核心结论

  • 全外显子组测序是诊断激素抵抗型肾病综合征单基因病因的敏感方法。
  • 激素抵抗型肾病综合征的分子遗传诊断可能对治疗和肾移植管理有重要影响。

研究设计与样本

  • 对33个已知的单基因激素抵抗型肾病综合征基因进行外显子数据分析。

主要发现

  • 在300个家庭中的74个(25%)检出20个已知致病基因之一的致病突变。
  • 在11个家庭(3.7%)中检出导致激素抵抗型肾病综合征表型模拟的基因突变。
  • 近亲家庭中已知激素抵抗型肾病综合征基因的致病突变检出率为38%,非近亲家庭为13%,先天性肾病综合征患儿为48%。
  • 检出突变最多的基因是NPHS1、PLCE1、NPHS2和SMARCAL1;另在28%的家庭中检出候选基因突变。

临床怎么用

  • 对激素抵抗型肾病综合征患者可考虑全外显子组测序以明确单基因病因。
  • 分子遗传诊断结果可用于指导治疗决策和肾移植管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Steroid-resistant nephrotic syndrome overwhelmingly progresses to ESRD. More than 30 monogenic genes have been identified to cause steroid-resistant nephrotic syndrome. We previously detected causative mutations using targeted panel sequencing in 30% of patients with steroid-resistant nephrotic syndrome. Panel sequencing has a number of limitations when compared with whole exome sequencing. We employed whole exome sequencing to detect monogenic causes of steroid-resistant nephrotic syndrome in an international cohort of 300 families. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Three hundred thirty-five individuals with steroid-resistant nephrotic syndrome from 300 families were recruited from April of 1998 to June of 2016. Age of onset was restricted to <25 years of age. Exome data were evaluated for 33 known monogenic steroid-resistant nephrotic syndrome genes. RESULTS: In 74 of 300 families (25%), we identified a causative mutation in one of 20 genes known to cause steroid-resistant nephrotic syndrome. In 11 families (3.7%), we detected a mutation in a gene that causes a phenocopy of steroid-resistant nephrotic syndrome. This is consistent with our previously published identification of mutations using a panel approach. We detected a causative mutation in a known steroid-resistant nephrotic syndrome gene in 38% of consanguineous families and in 13% of nonconsanguineous families, and 48% of children with congenital nephrotic syndrome. A total of 68 different mutations were detected in 20 of 33 steroid-resistant nephrotic syndrome genes. Fifteen of these mutations were novel. NPHS1, PLCE1, NPHS2, and SMARCAL1 were the most common genes in which we detected a mutation. In another 28% of families, we detected mutations in one or more candidate genes for steroid-resistant nephrotic syndrome. CONCLUSIONS: Whole exome sequencing is a sensitive approach toward diagnosis of monogenic causes of steroid-resistant nephrotic syndrome. A molecular genetic diagnosis of steroid-resistant nephrotic syndrome may have important consequences for the management of treatment and kidney transplantation in steroid-resistant nephrotic syndrome.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Warejko JK, Tan W, Daga A, et al. Whole Exome Sequencing of Patients with Steroid-Resistant Nephrotic Syndrome. Clin J Am Soc Nephrol. 2017. PMID: 29127259. doi:10.2215/CJN.04120417

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。